Live feed
Filing
SC 13D/A
SC 13D/A0001104659-20-136945·Chemomab Therapeutics Ltd.
Schedule 13D ownership disclosure
Anchiano Therapeutics Ltd.
Security class unavailable · CUSIP: 03280X102
Event date: 2020-12-17
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 0.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-20-136945
- Form type
- SC 13D/A
- Filer
- Chemomab Therapeutics Ltd.
- CIK
- CIK 1534248
- Filed
- Dec 18, 2020
- Reporting period
- Dec 17, 2020
- Description
- Schedule 13D beneficial ownership